The Spanish company CZ Vaccines and Irish firm Marrinovak Ltd have today launched the new aquaculture-focused pharmaceutical venture Aquatreck Animal Health.
Written by: editorial / The Fish site
Marrinnovak Chairman Patrick Smith said: “The mission of Aquatreck is to fast track innovative fish and shrimp disease prevention strategies by building effective open collaboration alliances of top talented teams to serve the global aquaculture industry’s sustainable future”
Aquatreck aims to support global aquaculture development providing autogenous, experimental and licensed vaccines and novel, innovative, reliable and accurate diagnostic services for the fish and shrimp farming industry.
Andrés Fernández Álvarez-Santullano, CEO of CZ Vaccines SA mentioned: “We have long experience as CMO GMP producers of fish vaccines for the last 25 years and we decided to focus to accelerate the sustainable global aquaculture growth by preventing the major fish and shrimp diseases so we launch today Aquatreck a new dynamic open innovation aquatic health company”
Dr. Panos Christofilogiannis Aquatreck Director indicated: “Aquatreck has long experience in fish vaccine development based on close collaboration and continuous interaction with fish farmers in order to develop comprehensive health management strategies. Aquatreck has top-level viral vaccine research and development facilities in Cambridge, UK, sub-unit fish vaccine research and development facilities in Dortmund, Germany, state of the art GMP Fish vaccine manufacturing facilities in Spain and close links with a vibrant network of fish immunology and pathology scientists around the world.”